Release
📈 Stocks
Resonant Acquires Labfish to Expand European Clinical Trial Capabilities
(just now)
Resonant acquires Labfish to enhance its European clinical trial infrastructure, adding specialized calibration and global partner depot capabilities to its service portfolio.